About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

The Core Message of ISCHEMIA

Published:

29 September 2020

Citation:

European Cardiology Review 2020;15:e64.

A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study P

Published:

15 May 2020

Citation:

European Cardiology Review 2020;15:e47.

Contemporary Cardiac MRI in Chronic Coronary Artery Disease

Published:

15 June 2020

Citation:

European Cardiology Review 2020;15:e50.

Pharmacogenetic Testing to Tailor Warfarin Therapy in Singapore

Published:

29 June 2020

Citation:

European Cardiology Review 2020;15:e53.